Allied Market Research published a report, titled, “Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer), by End User (Hospitals, Diagnostic centers, Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2030.” According to the report, the global cancer gene therapy industry generated $1.4 billion in 2020, and is expected to reach $11.4 billion by 2030, witnessing a CAGR of 23.3% from 2021 to 2030.
For Right Perspective, Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2605
Leading Market Players
- Bristol Myers Squibb Co.
- Novartis
- Amgen Inc.
- Glaxosmithkline PLC
- Kayropharma Therapeutics
- Gilead Sciences
- Adapta Immue
- Genulex Corporation
- SynerGene Therapeutics
- Shanghai Sunway Biotech
By Therapy
- Gene Induced Immunotherapy
- Oncolytic Virotherapy
- Gene Transfer
By End User
- Hospitals
- Diagnostic centers
- Research Institutes
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2605